Skip to main content
Log in

Preclinical stages in subjects at risk for neurological disorders: Can PET FDG tell us more?

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, Salerno JA, Heston LL, Rapoport SI, Horwitz B (1993) Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metabol 13:438–447

    Google Scholar 

  2. Azari NP, Pettigrew KD, Schapiro MB, Horwitz B (1993) Gender differences in patterns of hemispheric regional glucose metabolism (rCMRglc): A multiple regression/discriminant analysis of positron emission tomographic (PET) data. Soc Neurosci Abstr 19:1224

    Google Scholar 

  3. Azari NP, Pietrini P, Horwitz B, Pettigrew KD, Leonard HL, Rapoport JL, Schapiro MB, Swedo SE (1993) Individual differences in cerebral metabolic patterns during pharmacotherapy in obsessive-compulsive disorder: a multiple regression/discriminant analysis of positron emission tomographic data. Biol Psychiatry 34:798–809

    PubMed  Google Scholar 

  4. Azari NP, Pettigrew KD, Grady CL, Haxby JV, Horwitz B, Schapiro MB (1994) Abnormal pattern of cerebral glucose metabolic rates involving lan guage areas in young adults with Down syndrome. Brain Lang 46:1–20

    PubMed  Google Scholar 

  5. Azari NP, Pettigrew KD, Pietrini P, Horwitz B, Schapiro MB (1994) Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome. Dementia 5:69–78

    PubMed  Google Scholar 

  6. Clark CM, Ammann W, Martin WRW, Ty P, Hayden MR (1991) The FDG/PET methodology for early detection of disease: a statistical model. J Cereb Blood Flow Metabol 11:A96-A102

    Google Scholar 

  7. Kuwert T, Lange HW, Boecker H, Titz H, Aulich A, Wang B-C, Nayak U, Feinendegen LE (1993) Striatal glucose consumption in chorea-free subjects at risk for Huntington's disease. J Neurol 241:31–36

    PubMed  Google Scholar 

  8. Pietrini P, Schapiro MB, Kozachuk W, Aronin N, Marshal P, Kumar A, Kaye JA, Friedland R, Rapoport SI (1990) Cerebral glucose metabolism in familial inverted chorea assessed by positron emission tomography (abstract). J Nucl Med 31:740

    Google Scholar 

  9. Pietrini P, Azari NP, Grady CL, Salerno JA, Gonzales-Aviles A, Heston L, Pettigrew KD, Horwitz B, Schapiro MB (1993) Pattern of cerebral metabolic interactions in a subject at risk for Alzheimer's disease: a longitudinal evaluation. Dementia 4:94–101

    PubMed  Google Scholar 

  10. Pietrini P, Azari NP, Kozachuk W, Horwitz B, Kumar A, Salerno JA, Pettigrew KD, Grady GL, Haxby JV, Aronin N, Marshall P, Schapiro MB (1993) Striatal glucose metabolism and cerebral functional interactions in choreic disorders. A positron emission tomography study in familial inverted chorea. J Neuroimaging 3:151–159

    Google Scholar 

  11. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's Disease chromosomes. Cell 72:971–983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azari, N.P., Pietrini, P. Preclinical stages in subjects at risk for neurological disorders: Can PET FDG tell us more?. J Neurol 242, 112–114 (1995). https://doi.org/10.1007/BF00887827

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00887827

Keywords

Navigation